EDIT:NASDAQ
Editas Medicine Inc
US$1,72
arrow_upward
+0,58%(+0,0100) 1D
20 ພ.ຈ., 12 ໂມງ 8 ນາທີ 37 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
US$1,69
High
US$1,78
Low
US$1,66
Mkt. cap
265,46 ລ້ານ
Avg. vol.
2,24 ລ້ານ
Volume
720,37 ພັນ
52-wk high
US$3,94
52-wk low
US$1,66
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
Open
US$1,69
High
US$1,78
Low
US$1,66
Mkt. cap
265,46 ລ້ານ
Avg. vol.
2,24 ລ້ານ
Volume
720,37 ພັນ
52-wk high
US$3,94
52-wk low
US$1,66
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
1 ຊົ່ວໂມງກ່ອນ
S&P 500 Downward Gap Stocks in Nov. 20, 2026 Session
TradingView
·
46 ນາທີກ່ອນ
S&P 500 is near a bottom, but breadth still shows final low is not there yet – BTIG’s Krinsky
Traders Union
·
19 ນາທີກ່ອນ
S&P 500 P/E multiples range from 15.7x to 19.6x depending on EPS assumptions, Michael Kantro notes
FXEmpire
·
15 ນາທີກ່ອນ
S&P 500 Price Forecast: AI Stock Selloff Puts 7,000 in Focus
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
Foundedພ.ຈ. 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com